Awareness of cognitive decline in patients with alzheimer's disease: a systematic review and meta-Analysis

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Cacciamani, Federica
  • dc.contributor.author Houot, Marion
  • dc.contributor.author Gagliardi, Geoffroy
  • dc.contributor.author Dubois, Bruno
  • dc.contributor.author Sikkes, Sietske
  • dc.contributor.author Sánchez Benavides, Gonzalo
  • dc.contributor.author Denicolò, Elena
  • dc.contributor.author Molinuevo, José Luis
  • dc.contributor.author Vannini, Patrizia
  • dc.contributor.author Epelbaum, Stéphane
  • dc.date.accessioned 2022-06-07T06:38:31Z
  • dc.date.available 2022-06-07T06:38:31Z
  • dc.date.issued 2021
  • dc.description.abstract Background: Identifying a poor degree of awareness of cognitive decline (ACD) could represent an early indicator of Alzheimer's disease (AD). Objectives: (1) to understand whether there is evidence of poor ACD in the pre-dementia stages of AD; (2) to summarize the main findings obtained investigating ACD in AD; (3) to propose a conceptual framework. Data Sources: We searched Scopus, Pubmed, and the reference lists for studies published up to August 2020. Original research articles must report a measure of ACD and included individuals with AD dementia, or prodromal AD (or MCI), or being at risk for AD. Data Synthesis: All studies covering preclinical, prodromal, and AD dementia were systematically reviewed. We intended to perform a meta-analysis of empirical studies on preclinical AD or prodromal AD (or MCI), to compare ACD between clinical groups. Due to the paucity of literature on preclinical AD, meta-analysis was only possible for prodromal AD (or MCI) studies. Results: We systematically reviewed 283 articles, and conducted a meta-analysis of 18 articles on prodromal AD (or MCI), showing that ACD was not significantly different between patients with amnestic and non-amnestic MCI (SMD = 0.09, p = 0.574); ACD was significantly poorer in amnestic MCI (SMD = -0.56, p = 0.001) and mild AD (SMD = -1.39, p < 0.001) than in controls; ACD was also significantly poorer in mild AD than in amnestic MCI (SMD = -0.75, p < 0.001), as well as poorer than in non-amnestic MCI (SMD = -1.00, p < 0.001). We also discuss key findings on ACD in AD, such as its neural and cognitive correlates. Conclusions and Implications: We propose that patients may be complaining of their initial subtle cognitive changes, but ACD would soon start to decrease. The individual would show mild anosognosia in the MCI stage, and severe anosognosia in dementia. The evaluation of ACD (comparing self-report to cognitive scores or to informant-report) could be useful to guide the clinician toward a timely diagnosis, and in trials targeting early-stage AD.
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Cacciamani F, Houot M, Gagliardi G, Dubois B, Sikkes S, Sánchez-Benavides G, et al. Awareness of cognitive decline in patients with alzheimer's disease: a systematic review and meta-Analysis. Front Aging Neurosci. 2021 Aug 3; 13: 697234. DOI: 10.3389/fnagi.2021.697234
  • dc.identifier.doi http://dx.doi.org/10.3389/fnagi.2021.697234
  • dc.identifier.issn 1663-4365
  • dc.identifier.uri http://hdl.handle.net/10230/53392
  • dc.language.iso eng
  • dc.publisher Frontiers
  • dc.rights copyright © 2021 Cacciamani, Houot, Gagliardi, Dubois, Sikkes, Sánchez-Benavides, Denicolò, Molinuevo, Vannini and Epelbaum. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). http://creativecommons.org/licenses/by/4.0/. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri http://creativecommons.org/licenses/by/4.0/
  • dc.subject.keyword Alzheimer's disease
  • dc.subject.keyword Anosognosia
  • dc.subject.keyword Awareness
  • dc.subject.keyword Hypernosognosia
  • dc.subject.keyword Metamemory
  • dc.title Awareness of cognitive decline in patients with alzheimer's disease: a systematic review and meta-Analysis
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion